Indian Clinical Research Requires An Uplift

1
The 12th annual ISCR Conference was recently held
in Delhi, where the theme was Advancing the
frontiers of health. More than 500 clinical
research professionals attended the conference
to discuss how clinical trial reforms would build
the future of Indian research and opportunities
in India. The President of ISCR, Dr. Chirag
Trivedi, said, The changing profile of diseases
affecting the Indian population, the continuing
high prevalence of endemic diseases and the
emergence of lifestyle diseases all point to an
urgent need for greater investment in research
and innovation to address Indias increasing
disease burden and the incremental costs
associated with it. Stakeholders need to work
together to build and strengthen the clinical
research ecosystem in the country and create an
environment that encourages more research. At
the same time, there is a need for more education
and awareness about clinical research and its
benefits not just to participating patients, but
also to society at large.
Simultaneously, the Senior Director at Clinical
Cardiology Head of Research at Medanta, Dr,
Sanjay Mittal, said, Clinical research in India
is governed by robust local and global
regulations which makes India amongst the most
stringent clinical research regulatory
environments in the world. In such an
environment, we need to encourage,
2
not deter, not-for-profit organizations,
institutions, and Bio-pharma companies from
doing more research in India. Participating in
clinical research exposes us to the latest
trends and treatment protocols which, in turn,
benefits our practice and patients. At present,
the clinical trials being done in India is only
at 1.2, which is absolutely inadequate for a
country that has the second highest population in
the world, and the largest disease burden.
Looking at this small number, the ISCR annual
conference examined and discussed various
perspectives about clinical research, keeping in
mind everyone from patients to regulators, and
investigators to academia. Along with this,
there was also focus on medical writing, data
management, and Biostatistics. Dr. Chirag
Trivedi said that it is important for more to be
done to hightlight the robust regulatory
environment in India to stakeholders across the
globe, so that more investment in Indian
clinical research can be encouraged. This will
help to give momentum to the Indian Governments
Make In India initiative. In his words, he
said, We are as committed to the DCGIs
commitment to making safe, efficacious,
affordable and quality medicinal products for
our people. If we can have a Make in India for
other goods and services, why cannot we have a
Make in India for clinical research too?. For
our country to boost up on the clinical research
front, there are a number of factors that play
important roles. These include epidemiology,
disease prevelance, good infrastructure, future
commercial plans for new medicines, and much
more. One another very important element here is
qualified and well-trained professionals who can
come up with the best trials for all kinds of
diseases. More clinical research is required to
develop new and effective medicines and vaccines
so that unmet medical needs can be met, and the
disease burden can be reduced. If you realize
the problem that our countrys clinical research
system is facing, you can lend a helping hand by
taking up clinical research as a career, and
bringing yp your countrys clinical research
image, as well as boosting the health of every
Indian. For this, you can get enrolled at one of
the best institutes to study and gain a
legitimate post graduate diploma in clinical
research in Bangalore and one such institute is
Avigna Clinical Research Institute!